Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel B Walter

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody ResponsesKathleen M Neuzil, Evan J Anderson, Robert W Frenck, et al.
The Lancet. Infectious Diseases|December 16, 2022
Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trialEphraim L Tsalik, Nadine G Rouphael, Ruxana T Sadikot, et al.
Open Forum Infectious Diseases|August 12, 2022
Clinical Features and Treatment Outcomes of Pulmonary <i>Mycobacterium avium-intracellulare</i> Complex With and Without CoinfectionsGrace Wang, Jack T Stapleton, Arthur W Baker, et al.
JAMA Pediatrics|January 18, 2022
Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical TrialDerek J Williams, C Buddy Creech, Emmanuel B Walter, et al.
The Journal of Infectious Diseases|January 26, 2023
A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy AdultsJustin R Ortiz, David I Bernstein, Daniel F Hoft, et al.
Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
Influenza vaccine effectiveness against medically attended outpatient illness, United States, 2023-24 seasonJessie R Chung, Ashley M Price, Richard K Zimmerman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2025
Influenza vaccine effectiveness against medically attended outpatient illness, United States, 2023-24 seasonJessie R Chung, Ashley M Price, Richard K Zimmerman, et al.
Vaccine|September 28, 2025
Clinical immunization safety assessment (CISA) project: COVID-19 vaccine consultations and case reviewsPaula M Campbell, Gabriella J Ess, Allison Lale, et al.
The Lancet. Child & Adolescent Health|September 24, 2022
Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance studyIan Kracalik, Matthew E Oster, Karen R Broder, et al.
Influenza and Other Respiratory Viruses|June 26, 2024
Late-Season Influenza Vaccine Effectiveness Against Medically Attended Outpatient Illness, United States, December 2022-April 2023Jessie R Chung, Philip Shirk, Manjusha Gaglani, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody ResponsesKathleen M Neuzil, Evan J Anderson, Robert W Frenck, et al.
The Lancet. Infectious Diseases|December 16, 2022
Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trialEphraim L Tsalik, Nadine G Rouphael, Ruxana T Sadikot, et al.
Open Forum Infectious Diseases|August 12, 2022
Clinical Features and Treatment Outcomes of Pulmonary <i>Mycobacterium avium-intracellulare</i> Complex With and Without CoinfectionsGrace Wang, Jack T Stapleton, Arthur W Baker, et al.
JAMA Pediatrics|January 18, 2022
Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical TrialDerek J Williams, C Buddy Creech, Emmanuel B Walter, et al.
The Journal of Infectious Diseases|January 26, 2023
A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy AdultsJustin R Ortiz, David I Bernstein, Daniel F Hoft, et al.
Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
Influenza vaccine effectiveness against medically attended outpatient illness, United States, 2023-24 seasonJessie R Chung, Ashley M Price, Richard K Zimmerman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2025
Influenza vaccine effectiveness against medically attended outpatient illness, United States, 2023-24 seasonJessie R Chung, Ashley M Price, Richard K Zimmerman, et al.
Vaccine|September 28, 2025
Clinical immunization safety assessment (CISA) project: COVID-19 vaccine consultations and case reviewsPaula M Campbell, Gabriella J Ess, Allison Lale, et al.
The Lancet. Child & Adolescent Health|September 24, 2022
Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance studyIan Kracalik, Matthew E Oster, Karen R Broder, et al.
Influenza and Other Respiratory Viruses|June 26, 2024
Late-Season Influenza Vaccine Effectiveness Against Medically Attended Outpatient Illness, United States, December 2022-April 2023Jessie R Chung, Philip Shirk, Manjusha Gaglani, et al.
Pageof 14